Transcriptomic and Clinical Profiling Reveals LGALS3 as a Prognostic Oncogene in Pancreatic Cancer
These findings identify Galectin-3 as a key regulator of oncogenic programs and a potential prognostic biomarker in PDAC and other malignancies, with implications for therapeutic targeting.
Authors
- Paolo Fagone (ORCID: https://orcid.org/0000-0002-6694-1992)
- Michelino Di Rosa (ORCID: https://orcid.org/0000-0002-1837-9325)
- Gian Marco Leone (ORCID: https://orcid.org/0000-0002-8593-6179)
- Katia Mangano (ORCID: https://orcid.org/0000-0001-5920-4620)
- Sanja Mijatović (ORCID: https://orcid.org/0000-0001-9509-9098)
- José Francisco Muñóz-Valle (ORCID: https://orcid.org/0000-0002-2272-9260)
- Danijela Maksimović‐Ivanić (ORCID: https://orcid.org/0000-0002-8006-5079)
- Alexis Missael Vizcaíno‐Quirarte (ORCID: https://orcid.org/0009-0005-2443-0210)
- Ferdinando Nicoletti (ORCID: https://orcid.org/0000-0002-4570-8462)
- Grazia Scuderi (ORCID: https://orcid.org/0000-0002-4073-8224)
Institutions
- Universidad de Guadalajara (MX)
- University of Catania (IT)
- University of Belgrade (RS)
Publication Details
- Journal
- Genes
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3390/genes16101170
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00